2024-01-18FDA approves erdafitinib for locally advanced or metastatic urothelial carcinomaDrug Balversa (erdafitinib) · FGFR inhibitorConditionGenitourinary
2019-04-12FDA grants accelerated approval to erdafitinib for metastatic urothelial carcinomaDrug BALVERSA (erdafitinib) · FGFR inhibitorConditionGenitourinary